1. Home
  2. MNOV vs SCWO Comparison

MNOV vs SCWO Comparison

Compare MNOV & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • SCWO
  • Stock Information
  • Founded
  • MNOV 2000
  • SCWO 2021
  • Country
  • MNOV United States
  • SCWO United States
  • Employees
  • MNOV N/A
  • SCWO 27
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • SCWO Environmental Services
  • Sector
  • MNOV Health Care
  • SCWO Utilities
  • Exchange
  • MNOV Nasdaq
  • SCWO Nasdaq
  • Market Cap
  • MNOV 68.2M
  • SCWO 56.4M
  • IPO Year
  • MNOV 2005
  • SCWO N/A
  • Fundamental
  • Price
  • MNOV $1.32
  • SCWO $0.28
  • Analyst Decision
  • MNOV Strong Buy
  • SCWO
  • Analyst Count
  • MNOV 2
  • SCWO 0
  • Target Price
  • MNOV $7.00
  • SCWO N/A
  • AVG Volume (30 Days)
  • MNOV 13.0K
  • SCWO 896.7K
  • Earning Date
  • MNOV 08-07-2025
  • SCWO 08-13-2025
  • Dividend Yield
  • MNOV N/A
  • SCWO N/A
  • EPS Growth
  • MNOV N/A
  • SCWO N/A
  • EPS
  • MNOV N/A
  • SCWO N/A
  • Revenue
  • MNOV N/A
  • SCWO $673,267.00
  • Revenue This Year
  • MNOV N/A
  • SCWO $5,945.19
  • Revenue Next Year
  • MNOV N/A
  • SCWO $106.82
  • P/E Ratio
  • MNOV N/A
  • SCWO N/A
  • Revenue Growth
  • MNOV N/A
  • SCWO 161.19
  • 52 Week Low
  • MNOV $1.12
  • SCWO $0.25
  • 52 Week High
  • MNOV $2.55
  • SCWO $1.99
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 45.64
  • SCWO 45.13
  • Support Level
  • MNOV $1.32
  • SCWO $0.35
  • Resistance Level
  • MNOV $1.38
  • SCWO $0.44
  • Average True Range (ATR)
  • MNOV 0.05
  • SCWO 0.05
  • MACD
  • MNOV 0.00
  • SCWO -0.01
  • Stochastic Oscillator
  • MNOV 44.44
  • SCWO 0.00

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

Share on Social Networks: